ACHV - Achieve Life Sciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.5400
-0.0400 (-1.12%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close3.5800
Open3.5500
Bid3.4500 x 800
Ask3.6000 x 800
Day's Range3.4700 - 3.6000
52 Week Range1.0400 - 14.6000
Volume84,404
Avg. Volume1,690,080
Market Cap23.793M
Beta (3Y Monthly)2.68
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga16 days ago

    The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 1) Abbott Laboratories (NYSE: ABT ) AEterna Zentaris Inc. ...

  • Zacks Small Cap Research24 days ago

    ACHV: Fiscal Year 2018 Operational and Financial Results

    Achieve Life Sciences, Inc. (ACHV) released its financial results for 2018 and filed the companion 10-K for the year ending December 31, 2018 on March 14, 2019. An investor conference call was held following the release to discuss recent achievements and financial results. Since our initiation, the company initiated a maximum tolerated dose (MTD) trial to examine the feasibility of a higher dose as they move into a Phase III trial.

  • Zacks Small Cap Researchlast month

    ACHV: A Reason to Quit is a Reason to Buy

    Achieve Life Sciences, Inc. (ACHV) is developing cytisinicline, historically known as cytisine, for nicotine addiction. Achieve has licensed cytisinicline for development and commercialization in the United States and most other geographies around the world including parts of Europe, the Middle East, Africa and Asia. The drug formulation has been used by over 20 million smokers in Central and Eastern Europe for smoking cessation and also in over 2,000 subjects in previously conducted investigator-led Phase 3 clinical trials.

  • Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful?
    Simply Wall St.2 months ago

    Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful?

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! The big shareholder groups in Achieve Life Sciences, Inc. (NASDAQ:ACHV)Read More...

  • MarketWatch2 months ago

    Achieve Life Sciences' stock rockets on heavy volume after update results of smoking-cessation drug trial

    Shares of Achieve Life Sciences Inc. rocketed 73% to pace all premarket gainers in active trade Friday, after the company reported upbeat results from a trial of its smoking-cessation drug. Trading volume reached 1.8 million shares ahead of the open, compared with the full-day average of about 151,000 shares. The company said it evaluated repeat doses of cytisinicline in 26 healthy volunteer smokers, who smoked an average 17.2 cigarettes a day. By the 26th day of treatment, there was an averag80% reduction in cigarettes smoked, 82% reduction in expired carbon monoxide and 46% had stopped smoking. Cytisinicline was well tolerated, with only "transient, mild-to-moderate headache" as the most common adverse event. "Given the short 25-day treatment period, the abstinence rates observed are impressive, particularly since subjects were not required to commit to quitting and received minimal behavioral support during the study," said Chief Medical Officer Cindy Jacobs. The stock has tumbled 87% over the past 12 months through Thursday, while the S&P 500 has gained 2.6%.

  • 5 Top Rising P/E Stocks to Enjoy Solid Gains
    Zacks4 months ago

    5 Top Rising P/E Stocks to Enjoy Solid Gains

    Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

  • Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals
    Zacks5 months ago

    Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals

    Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals

  • 5 Top-Ranked Rising P/E Stocks to Lure Investors
    Zacks5 months ago

    5 Top-Ranked Rising P/E Stocks to Lure Investors

    Inside the top-ranked stocks that have been exhibiting rising P/E ratios.

  • InvestorPlace6 months ago

    Achieve Life Sciences Stock Will Probably Tumble Further

    After an impressive 48.8% gain last week by Achieve Life Sciences (NASDAQ:ACHV) stock, ACHV stock has given up nearly all of its gains this week. ACHV stock price jumped on Sept. 27 after the company reported the results of a clinical study, but the shares went on to lose practically all of their gains by Oct. 1. ACHV stated that a new formulation of its  smoking cessation aid – cytisine – showed similar bioavailability when the subjects were fed and when they fasted.

  • Benzinga9 months ago

    Achieve Life Sciences Shares Surge On Development Plan For Smoking Cessation Candidate

    Achieve Life Sciences Inc (NASDAQ: ACHV) shares are skyrocketing as the clinical-stage biotech moves one step closer to filing a New Drug Application for its smoking cessation pipeline candidate cytisine. The company said it will conduct a Phase 2b optimization trial in about 250 smokers in the U.S., with various dosing schedules to determine efficacy, safety and compliance profiles.

  • Benzinga10 months ago

    Achieve Life Sciences Shares Rip Higher On Positive Data For Smoking Cessation Drug

    Achieve Life Sciences Inc (NASDAQ: ACHV ) shares were posting double-digit gains Tuesday on roughly 83 times the stock's average volume. The stock was up 31 percent at the time of publication at $4.97. ...

  • Should You Be Concerned About Achieve Life Sciences Inc’s (NASDAQ:ACHV) Shareholders?
    Simply Wall St.11 months ago

    Should You Be Concerned About Achieve Life Sciences Inc’s (NASDAQ:ACHV) Shareholders?

    In this article, I will take a quick look at Achieve Life Sciences Inc’s (NASDAQ:ACHV) recent ownership structure – an unconventional investing subject, but an important one. Ownership structure ofRead More...